Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Cancer
|
June 2, 2007
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction
, Esteban Celis
Cancer Research
|
September 7, 2007
Toll-like receptor ligands energize peptide vaccines through multiple paths
Esteban Celis
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 23, 2005
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice
Tsuyoshi Itoh, Esteban Celis
Cancer Research
|
October 18, 2002
Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen
Jun Lu, Esteban Celis
Oncoimmunology
|
July 23, 2014
A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway
Toshihiro Nagato, Esteban Celis
Cancer Immunology, Immunotherapy : CII
|
April 25, 2012
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers
Kelly Barrios, Esteban Celis
Immunological Reviews
|
March 28, 2008
Multiple roles for CD4+ T cells in anti-tumor immune responses
Richard Kennedy, Esteban Celis
Current Opinion in Immunology
|
May 24, 2008
Peptide epitope identification for tumor-reactive CD4 T cells
Hiroya Kobayashi, Esteban Celis
Cancer Immunology, Immunotherapy : CII
|
May 20, 2015
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Zili Wang, Esteban Celis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides
Jonathan Baines, Esteban Celis
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Cancer
|
June 2, 2007
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction
, Esteban Celis
Cancer Research
|
September 7, 2007
Toll-like receptor ligands energize peptide vaccines through multiple paths
Esteban Celis
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 23, 2005
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice
Tsuyoshi Itoh, Esteban Celis
Cancer Research
|
October 18, 2002
Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen
Jun Lu, Esteban Celis
Oncoimmunology
|
July 23, 2014
A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway
Toshihiro Nagato, Esteban Celis
Cancer Immunology, Immunotherapy : CII
|
April 25, 2012
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers
Kelly Barrios, Esteban Celis
Immunological Reviews
|
March 28, 2008
Multiple roles for CD4+ T cells in anti-tumor immune responses
Richard Kennedy, Esteban Celis
Current Opinion in Immunology
|
May 24, 2008
Peptide epitope identification for tumor-reactive CD4 T cells
Hiroya Kobayashi, Esteban Celis
Cancer Immunology, Immunotherapy : CII
|
May 20, 2015
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Zili Wang, Esteban Celis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides
Jonathan Baines, Esteban Celis
Page
of 13